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Neuraxial and locoregional anesthesia are considered techniques of choice for multiple procedures,1–4 and are frequently chosen as an alternative to general anesthesia. In this context, diverse adjuvants are often administrated in conjunction with local anesthetics (LAs). The adjunction of epinephrine to LAs is widely used for 
BACKGROUND:  This systematic review examines the benefit and harm of adding epinephrine 
to local anesthetics for epidural, intrathecal, or locoregional anesthesia.
METHODS: We searched electronic databases to October 2017 for randomized trials comparing 
any local anesthetic regimen combined with epinephrine, with the same local anesthetic regi-
men without epinephrine, reporting on duration of analgesia, time to 2 segments regression, 
or any adverse effects. Trial quality was assessed using the Cochrane risk of bias tool and a 
random-effects model was used. Trial sequential analyses (TSA) were applied to identify the 
information size (IS; number of patients needed to reach a definite conclusion) and were set to 
detect an increase or decrease of effect of 30%–50%, depending on the end point considered. 
Alpha levels were adjusted (1%) for multiple outcome testing.
RESULTS: We identified 70 trials (3644 patients, 17 countries, from 1970 to 2017). Median 
number of patients per trial was 44 (range, 9–174). Thirty-seven trials (1781 patients) tested epi-
nephrine for epidural, 27 (1660) for intrathecal, and 6 (203) for locoregional anesthesia (sciatic, 
femoral, popliteal, axillary blocks). TSA enabled us to conclude that adding epinephrine to epidural 
local anesthetics could not decrease postoperative pain intensity by 30%, and did not impact the 
risk of intraoperative arterial hypotension. IS was insufficient to conclude on the impact of epi-
nephrine on the risk of motor block (IS, 4%), arterial hypotension (20%), urinary retention (23%), or 
pain intensity at rest (27%) during labor. TSA confirmed that adding epinephrine to intrathecal local 
anesthetics increased the duration of motor block (weighted mean difference [WMD] 64 minutes; 
99% CI, 37–91), analgesia (WMD 34 minutes; 99% CI, 6–62), and the time to 2 segments regres-
sion (WMD 20 minutes; 99% CI, 11–28). IS was insufficient to conclude on its impact on arterial 
hypotension (IS, 15%), or when administrated in a combined spinal-epidural, on motor block (IS, 
11%) or arterial hypotension (IS, 11%). Adding epinephrine to local anesthetics for a locoregional 
block increased the duration of analgesia (WMD 66 minutes; 98% CI, 32–100]).
CONCLUSIONS: Adding epinephrine to intrathecal or locoregional local anesthetics prolongs 
analgesia and motor block by no more than 60 minutes. The impact of adding epinephrine to 
epidural local anesthetics or to a combined spinal-epidural remains uncertain.  (Anesth Analg 
2018;127:228–39)
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KEY POINTS
• Question: What are the benefits and harms of adding epinephrine to local anesthetics for 
epidural, intrathecal, or locoregional anesthesia?
• Findings: Evidence exists that adding epinephrine to intrathecal or locoregional local anes-
thetics prolongs analgesia and motor block by no more than 60 minutes. Available evidence 
is insufficient to conclude on other outcomes in these settings, or that adding epinephrine to 
epidural local anesthetics has any impact at all.
• Meaning: Further studies are required to clarify the potential impact of adding epinephrine to 
epidural local anesthetics and to establish dose-responsiveness of epinephrine when added 
to local anesthetics for epidural, intrathecal, or locoregional anesthesia.
Copyright © 2018 International Anesthesia Research Society
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these regional techniques and is thought to prolong anes-
thesia via a vasoconstrictive effect delaying LA clearance 
from the injection site,5,6 and via α2-adrenoreceptors located 
in the spinal cord dorsal horn.7
The benefits and the incidence of adverse effects associ-
ated with the use of epinephrine are not clearly defined. A 
systematic review of randomized controlled trials (RCTs) 
investigating epidural epinephrine in various settings, but 
excluding labor, did not include sufficient data to reach valid 
conclusions.8 Intrathecal epinephrine was studied in a meta-
analysis that included trials that tested epinephrine added to 
LAs or to opioids, making the results difficult to interpret.9
In the present analysis, we assessed the impact of adding 
epinephrine to a LA for epidural, intrathecal, or locoregional 
anesthesia. Any perineural or plexus LA administration 
was classified as locoregional anesthesia. We aimed to check 
whether adding epinephrine resulted in any clinically rel-
evant beneficial or harmful effect. Moreover, we aimed to 
identify, using trial sequential analysis (TSA), whether addi-
tional trials, in these different settings, were still needed.
METHODS
Protocol and Registration
The protocol of this meta-analysis was registered in 
PROSPERO (CRD: 42015026148). Changes to the protocol 
are notified in the section “Data items.” We followed the 
Preferred Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA) recommendations for data reporting.10
Inclusion Criteria
We included RCTs comparing any regimen of any LA with 
epinephrine (experimental intervention) with the same LA 
regimen but without epinephrine (control intervention). 
Trials were considered if they tested perineural or plexus 
blocks, or intrathecal or epidural anesthesia in adults (≥18 
years) undergoing any surgery, or in parturients during labor. 
When an additional adjuvant to the LA was used (eg, opioids 
or clonidine), the trial was included as long as the adjuvant 
was used in a strictly controlled manner (ie, administration 
of the same regimen of the adjuvant in both experimental 
and control groups). For eligibility, a study had to report on 
at least one of the following outcomes: duration of analgesia 
(defined as the time in minutes from injection to first request 
of analgesia), time from injection to 2 segments regression 
(for intrathecal anesthesia), need for supplementary LA or 
systemic rescue analgesia, or incidence of any adverse effects.
Noninclusion Criteria
We did not consider trials reporting on digital nerve blocks, 
blocks for dentistry, LA infiltration (for instance, subcutane-
ously) or if epinephrine was added to a regional anesthesia 
regimen in the absence of an LA. Furthermore, we did not 
consider studies published as abstracts only.
Information Sources and Searches
Databases (MEDLINE, CENTRAL, EMBASE, GOOGLE 
SCHOLAR) were searched using a high-sensitivity and 
low-specificity search strategy. The key words “epidural,” 
“peridural,” “extradural,” “spinal,” “intrathecal,” “block,” 
“epinephrine,” “adrenaline,” “analgesia,” and “anesthesia” 
were combined using the Boolean meanings of “AND” and 
“OR.” The last electronic search was performed in October 
2016. We also searched trial registries in November 2017 to 
identify potentially eligible trials. Bibliographies of retrieved 
articles were checked for additional references. No language 
restriction was applied (Supplemental Digital Content, 
Search Strategy, http://links.lww.com/AA/C359).
Study Selection
Studies were selected independently by 2 authors (C.T., M.Z.). 
One (C.T.) screened all references based on titles and abstracts 
and excluded references that obviously did not adhere to our 
inclusion criteria. Criteria for inclusion and noninclusion were 
checked by a further author (A.S.). Full reports were screened 
for final inclusion by 2 authors (C.T., A.S.).
Data-Collecting Process
One author (C.T.) extracted all relevant information from 
the original reports. Another author (A.S.) checked all 
extracted data. Discrepancies were resolved through discus-
sion with an additional author (N.E.). Authors of included 
studies were contacted to obtain supplemental relevant 
information; for instance, we asked them for exact values 
of means and standard deviations (SDs) that were reported 
in graphs only, or for data reported as medians with ranges, 
or for unpublished outcomes. If contacting the authors was 
unsuccessful, we extracted the data from the graphs, and 
extrapolated means and SD from the published medians 
and ranges.11
Data Items
We extracted information on journal name, year of publica-
tion, first author’s name, type of surgery and anesthetic pro-
cedures, number of randomized, excluded, and eventually 
analyzed patients, type and regimen of the LA, and regimen 
of epinephrine and of other adjuvants.
Predefined primary outcomes for the assessment of 
the impact of adding epinephrine to LAs were duration 
of analgesia, time to 2 segments regression (for intrathecal 
anesthesia), total consumption of LAs, and adverse effects. 
While going through the studies, we realized that some of 
our predefined outcomes were not relevant for all types of 
regional anesthesia. For instance, duration of analgesia is 
less an issue when analgesia is performed with an epidural 
catheter since reinjection of the anesthetic drug is possible. 
To focus on clinically relevant outcomes, we redefined out-
comes of primary interest according to anesthesia tech-
niques and settings (Table 1). For instance, we assumed that 
the adjunction of epinephrine to epidural LAs was useful 
only if it decreased the incidence of arterial hypotension or 
urinary retention or if it prolonged the duration of postop-
erative analgesia. Similarly, we assumed that the adjunction 
of epinephrine to LAs for a plexus block was useful only if 
it prolonged analgesia without prolonging motor block. All 
other outcomes that were reported in the original studies 
were extracted and considered as secondary outcomes.
Risk of Bias in Individual Studies
We assessed the quality of individual trials using the 
Cochrane risk of bias tool which contains 6 items rated as 
Copyright © 2018 International Anesthesia Research Society. Unauthorized reproduction of this article is prohibited.
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low, high, or unclear risk of bias.12 Because small trials tend 
to overestimate treatment effects, study size was included 
under the criterion “other bias.” For the purpose of this 
analysis, we arbitrarily defined a study size <50 patients as 
a high risk of bias. Quality assessment was done by 1 author 
(C.T.) and checked by another author (A.S.). Discrepancies 
were discussed with a third author (N.E.).
Statistical Analyses
All analyses were stratified according to the 3 routes of epi-
nephrine administration (epidural, intrathecal, locoregional), 
and subgroups were computed within each stratum accord-
ing to the different clinical settings (labor, perioperative, post-
operative) to provide information that is clinically relevant.
There was an arbitrary pre hoc decision to analyze data 
only when they were reported in at least 3 studies or 100 
patients. For continuous outcomes, we extracted means and 
SDs for experimental and control groups, as reported in the 
original trials. Mean differences with 95% CIs were then 
computed for each study separately and a pooled estimate 
of mean differences was computed as a weighted mean dif-
ference (WMD) using the inverse variance method for the 
calculation of the weights of the different studies. For binary 
outcomes, we extracted the cumulative number of events 
reported in the experimental and control groups separately 
and computed an estimation of the effect of the interven-
tion on the outcome using relative risks (RRs) and 95% CIs. 
The Mantel-Haenszel method was then used to pool all the 
RRs across studies. There was a pre hoc decision to use a 
random-effects model for all analyses because the impact of 
adding epinephrine to an LA may differ according to differ-
ent study settings. In case of statistical evidence of heteroge-
neity (P value for the test of heterogeneity <.1), we intended 
to perform sensitivity analyses to search for the sources of 
heterogeneity.
For studies that compared different doses of epinephrine 
added to a single LA regimen, we checked whether the dif-
ferent doses resulted in statistically significant differences in 
outcomes. When the data were homogeneous (P value for 
the test of heterogeneity >.1), we pooled them. If not (P < .1), 
we selected the dose that was closest to the doses examined 
in the other trials.
We adapted the α levels of our analyses to account for 
multiple outcome testing within each of the 3 routes of epi-
nephrine administration (epidural, intrathecal, locoregional), 
taking into account the subgroup analyses performed for the 
different clinical settings (labor, perioperative, postopera-
tive) based on the pragmatic recommendations by Jakobsen 
et al,13 which suggest dividing the standard 0.05 with the 
value situated halfway between 1 (no adjustment) and the 
number of primary outcomes compared (Bonferroni adjust-
ment). For all primary outcomes, related to the epidural 
administration of epinephrine, this resulted in an α level 
of .01 and a 99% CI around the pooled point estimates 
(4 outcomes, 9 subgroups (0.05/[{9 + 1}/2]) = 0.01) instead of 
the conventional 0.05 and 95% CI. Similarly, the α level was 
set at .01 for all primary outcomes related to the intrathe-
cal administration of epinephrine (6 outcomes, 7 subgroup 
analyses), and at .02 for those related to intrablock adminis-
tration of epinephrine (3 outcomes, no subgroup analyses). 
For secondary outcomes, all α levels were set at .01.
Meta-analyses were performed using RevMan ver-
sion 5.3.5 (The Nordic Cochrane Centre, The Cochrane 
Collaboration, Copenhagen, Denmark), STATA 15 (StataCorp, 
College Station, TX), and Microsoft Excel version 12.3.6 for 
Mac (Microsoft, Redmond, WA). For all outcomes of pri-
mary interest, we used funnel plots to visually assess the 
risk of publication bias. We additionally performed TSA 
(Trial Sequential Analysis, version 0.9.5.5 beta; Copenhagen 
Trial Unit, Copenhagen, Denmark, 2016), to add information 
regarding the number of patients required to reach a definite 
conclusion, considering a power of 80%, an α level of 1% (or 
2% for locoregional anesthesia), and a 2-sided test.14 For all 
TSA analyses, we assumed that adding epinephrine to an 
LA would be considered clinically relevant if it changed the 
outcome by 30%–50% depending on the end point. Details 
of assumptions tested are provided in Supplemental Digital 
Content, Table A, http://links.lww.com/AA/C359.
RESULTS
Selection of Trials
We retrieved 183 potentially relevant trial reports of which 
70 underwent further analyses (Figure).15–83
Trial Characteristics
The 70 trials were published between 1970 and 2017 and 
included data on 3644 patients (Supplemental Digital Content, 
Table B, http://links.lww.com/AA/C359). They originated 
from 17 countries: United States (28 trials); United Kingdom 
(8); France (5); Belgium and Japan (4 each); Turkey and 
Finland (3 each); China, India, Korea, the Netherlands, and 
Sweden (2 each); and Canada, Ireland, Republic of Macedonia, 
Switzerland, and Taiwan (1 each). All reports were published 
in English except 2 that were published in French.57,67 Median 
number of patients per trial was 44 (range, 9–174).
Table 1.  Modified Outcomes of Primary Interest
Route of 
Administration Outcomes of Interest Settings
Epidural Motor block
Arterial hypotension
Urinary retention
VAS pain at rest
Labor, postoperative 
analgesia
Labor, surgical 
anesthesia, 
postoperative 
analgesia
Labor, postoperative 
analgesia
Labor, postoperative 
analgesia
Intrathecal Arterial hypotension
Duration of analgesia
Duration of motor block
Time to 2 segments 
regression
Motor block
Urinary retention
Labor CSE, surgical 
anesthesia
Surgical anesthesia
Surgical anesthesia
Surgical anesthesia
Labor CSE
Labor CSE
Locoregional 
anesthesia
Duration of motor block
Duration of analgesia
Time to reach adequate 
block
Surgical anesthesia
Surgical anesthesia
Surgical anesthesia
Abbreviations: CSE, combined spinal-epidural anesthesia; VAS, visual analog 
scale.
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In 37 trials (1781 patients), epinephrine was added to 
epidural LAs. In 12 of those, regimens were administered 
continuously through a catheter. In 27 trials (1660 patients), 
epinephrine was added to intrathecal LAs; of those, 8 were 
using a combined spinal-epidural (CSE) technique. Finally, 
in 6 trials (203 patients), epinephrine was added to an LA for 
locoregional anesthesia (sciatic, femoral, popliteal, axillary).
LAs used were bupivacaine (40 trials), lidocaine (10), 
ropivacaine (9), tetracaine (6), chloroprocaine (3), levobupi-
vacaine (2), and lidocaine CO2 or mepivacaine (1 trial each; 
numbers do not add up because 2 trials were using 2 dif-
ferent LAs). Further adjuvants were used in 29 trials and 
included fentanyl (18 trials), sufentanil (6), morphine (3), 
and butorphanol or clonidine (1 trial each).
Studies were performed in a variety of settings: labor 
(24 trials), cesarean delivery (15), orthopedic (13), urologic 
(6), general (4), gynecologic (3), lumbar spine (2), or vascu-
lar surgery (1). In 2 trials, patients underwent a variety of 
surgical interventions.47,79 In 4 trials, general anesthesia was 
systematically administrated in combination with regional 
anesthesia,69,72,76,80 and in 5 trials, general anesthesia was 
used as a rescue in case of failed regional anesthesia.20,22,25,35,58
Definitions of the end points varied among original 
studies. We used the definitions as reported in the trials 
(Supplemental Digital Content, Table C, http://links.lww.
com/AA/C359).
Risks of biases are shown for each trial in Supplemental 
Digital Content, Figure A, http://links.lww.com/AA/C359.
We contacted the authors of 41 articles and asked for 
additional data; the authors of 14 articles responded and 
additional unpublished data from 3 trials could eventually 
be added to our analyses.39,40,71
Epidural Epinephrine
We found no evidence that adding epinephrine to an epi-
dural LA changed any of the primary outcomes. Sample 
sizes were either too small to reach a definite conclusion 
(motor block, urinary retention) or sufficient to conclude on 
the futility of this adjunction (hypotension, pain intensity; 
Table 2, Supplemental Digital Content, Table A and Figures 
B1–B4, http://links.lww.com/AA/C359). Similarly, we 
found no evidence of an impact of epinephrine administra-
tion on any of the secondary outcomes (Table 3).
The impact of epidural epinephrine according to the 
different clinical settings is described in the following 3 
paragraphs.
Labor Analgesia. Seventeen trials (886 patients) 
tested epinephrine added to epidural LAs for labor 
analgesia. Regimens were administrated as boluses in 11 
trials,15–18,36,37,44,45,56,73,82 and via a continuous infusion in 
6 trials.32,33,52,54,62,64 LAs were bupivacaine (13 trials), and 
chloroprocaine, levobupivacaine, lidocaine, or ropivacaine 
(1 trial each). Concentrations of epinephrine ranged from 
1 to 5 µg·mL−1. The required sample sizes were not reached 
to definitely conclude on the impact of epinephrine on the 
duration of motor block: information size (IS) (4%), arterial 
hypotension (20%), urinary retention (23%), or pain intensity 
at rest (27%). There were too few trials to assess graphical 
evidence of publication bias (Table 2, Supplemental Digital 
Content, Table A and Figures B1-2, B2-2, B3-1, and B4-2, 
http://links.lww.com/AA/C359). We found no evidence 
of an impact of epinephrine on the incidences of ephedrine 
requirement, postoperative nausea and vomiting (PONV), 
pruritus, sedation, Apgar <7 at 1 minute, umbilical arterial 
pH, the need for cesarean delivery, or for instrumentation 
for delivery (Table 3).
Surgical Anesthesia. Fifteen trials (605 patients) 
tested epinephrine added to epidural LAs for surgical 
anesthesia. Regimens were administrated as boluses in 14 
trials,21,23,26,34,38,49,50,53,58,61,65,72,79,81 and via a continuous infusion 
Figure. Flowchart. GA indicates general anesthesia; 
LA, local anesthetic; LRA, locoregional anesthesia 
(*axillary, popliteal, femoral, sciatic); RCT, random-
ized controlled trial.
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in 1 trial.76 LAs were bupivacaine (9 trials), lidocaine or 
ropivacaine (2 each), and chloroprocaine or levobupivacaine 
(1 each). Concentrations of epinephrine ranged from 2.5 to 
5 µg·mL−1. The addition of epinephrine to epidural LAs 
showed no impact on the risk of intraoperative arterial 
hypotension. Although IS was not reached (50%), the limits 
of futility were crossed suggesting that further trials were 
unlikely to demonstrate a change of 20% on this outcome 
(Table 2, Supplemental Digital Content, Table A and Figures 
B2-3, http://links.lww.com/AA/C359). There was no 
evidence either that epidural epinephrine had an impact on 
the risks of ephedrine requirement, bradycardia, or PONV, 
or on umbilical arterial pH (Table 3).
Postoperative Analgesia. Five trials (290 patients) tested 
epinephrine added to a postoperative infusion of epidural 
LAs. Among them, 3 used a fixed infusion rate39,40,69 and 2 
used a fixed infusion rate in addition to patient-controlled 
epidural analgesia.29,30 LAs were bupivacaine (3 trials) and 
ropivacaine (2 trials). Concentrations of epinephrine ranged 
from 0.5 to 5 µg·mL−1. There was insufficient evidence 
to definitely conclude on the impact of epinephrine on 
motor block (IS, 31%). There were too few trials to test for 
publication bias. There was sufficient evidence to conclude 
that epinephrine did not decrease pain intensity at rest by 
>30% (Table 2, Supplemental Digital Content, Table A and 
Figures B4-3, http://links.lww.com/AA/C359). Incidences 
of PONV, pruritus, and sedation were not impacted by 
epinephrine (Table 3).
Intrathecal Epinephrine
We found evidence that adding epinephrine to an intra-
thecal LA significantly prolonged the duration of anal-
gesia, motor block, and time to 2 segments regression. 
Its impact on the risk of hypotension and on the propor-
tion of motor block when administrated in a CSE regimen 
remained unclear due to insufficient sample size (Table 2, 
Supplemental Digital Content, Table A and Figures B5–B9, 
http://links.lww.com/AA/C359). Similarly, we found no 
evidence of any impact of epinephrine on any of the second-
ary outcomes (Table 3). The impact of intrathecal epineph-
rine, according to the different clinical settings, is described 
in the following 2 paragraphs.
Surgical Anesthesia. Twenty-one studies (1289 patients) 
examined the effect of epinephrine added to intrathecal LAs 
for surgical procedures.19,20,22,25,27,28,31,43,47,48,51,55,59,60,66–68,75,77,83,84 
Two of those were using a CSE technique.48,68 From these 
trials, we extracted the end points duration of analgesia 
and time to highest sensory block before the first epidural 
injection. LAs were bupivacaine (9 trials), tetracaine 
and lidocaine (5 each), and chloroprocaine (1). In 1 trial, 
both bupivacaine and tetracaine were tested.60 Doses 
of epinephrine ranged from 15 to 500 µg. Intrathecal 
epinephrine significantly increased the duration of analgesia 
(WMD 34 minutes [99% CI, 5.9–62]; P = .002), the duration 
of motor block (64 minutes [37–91]; P > .001), and the time to 
2 segments regression (20 minutes [11–28]; P < .001). The IS 
required was reached for the time to 2 segments regression. 
Although it was not reached for duration of analgesia and 
of motor block, the limits of the α spending boundaries  
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were crossed (Table 2, Supplemental Digital Content, Table 
A and Figures B6–B8, http://links.lww.com/AA/C359). 
The impact of intrathecal epinephrine on the incidence of 
hypotension remained unclear due to insufficient sample 
size (Table  2, Supplemental Digital Content, Table A and 
Figure B5-2, http://links.lww.com/AA/C359).
In addition, the incidences of bradycardia, ephedrine 
requirement, PONV, and pruritus; the time to reach the 
highest sensory block; and pain intensity at rest were ana-
lyzed. Intrathecal epinephrine increased the time to reach 
the highest sensory block (1.4 minutes [99% CI, 0.2–2.9]; P 
< .001). There was no evidence of an impact of adding epi-
nephrine on the other end points (Table 3).
Combined Spinal-Epidural for Labor Analgesia. Six trials 
(371 patients) tested epinephrine added to intrathecal LAs 
for labor analgesia using the CSE technique.24,41,42,46,63,78 
LAs were bupivacaine (5 trials) and ropivacaine (1). Doses 
of epinephrine ranged from 2.25 to 200 µg. There were 
not enough data to definitely conclude on the impact 
of epinephrine on motor block (IS, 11%) or on arterial 
hypotension (11%) (Table 2, Supplemental Digital Content, 
Table A and Figures B5-3 and B9, http://links.lww.com/
AA/C359). Incidences of ephedrine requirement, PONV, 
pruritus, need for cesarean delivery or instrumentation, 
or the risk of neonatal bradycardia were not impacted by 
epinephrine (Table 3).
Locoregional Anesthesia
Six trials (203 patients) tested epinephrine added to an LA 
for locoregional anesthesia.35,57,70,71,74,80 LAs used were ropi-
vacaine (3 trials), lidocaine (1), and mepivacaine (1). One 
trial tested both lidocaine and lidocaine CO2.57 Doses of epi-
nephrine ranged from 100 to 300 µg. Epinephrine increased 
the duration of analgesia (WMD 66 minutes [98% CI, 32–
100]); the required IS was reached (Table 2, Supplemental 
Digital Content, Table A and Figure B10, http://links.lww.
com/AA/C359). Incidence of block failure was reported 
in 4 trials; we found no evidence that it was influenced by 
epinephrine (Table  3).35,70,71,80 Two studies reported on the 
duration of motor block; they both suggested that epineph-
rine prolonged the motor block, but there were not enough 
patients to allow for data computation.35,74
Sensitivity Analyses
Significant heterogeneity was found for some of the pri-
mary outcomes.
Epidural for Labor Analgesia. The degree of heterogeneity could 
be decreased for the outcome arterial hypotension by regrouping 
the trials using bupivacaine (P for heterogeneity = .12); this did 
not change our estimate significantly (RR of this subgroup 
changed from 0.70 [99% CI, 0.27–1.81] to 0.51 [0.19–1.37]).
Intrathecal Anesthesia for Surgery. The degree of 
heterogeneity could be decreased by regrouping trials 
according to the LA used for the outcome duration of 
analgesia. This did not change our estimates.
For all other primary outcomes, the number of trials or 
patients per stratum were insufficient to perform sensitivity 
analyses.
DISCUSSION
Summary of Findings
We assessed the impact of adding epinephrine to an LA for 
regional anesthesia. We were able to conclude that adding 
epinephrine to epidural LAs did not decrease postoperative 
pain intensity by at least 30%, and did not impact the risk 
of intraoperative arterial hypotension. Also, adding epi-
nephrine to intrathecal LAs increased the duration of motor 
block by about 60 minutes, of analgesia by about 30 min-
utes, and the time to 2 segments regression by 20 minutes. 
Adding epinephrine to LAs for a locoregional block signifi-
cantly increased the duration of analgesia by about 60 min-
utes. Other important results of this systematic review were 
to identify the knowledge gaps. The IS, thus the number of 
patients needed to reach a definite conclusion, was insuffi-
cient to conclude on the impact of epinephrine on a variety 
of end points, for instance, on motor block when adminis-
trated through an epidural catheter, or on the risk of arterial 
hypotension when administrated intrathecally.
What Is Already Known on This Subject?
The role of epinephrine adjunction has been addressed in 
2 systematic reviews.8,9 One, examining the impact of add-
ing epinephrine to epidural LAs in 7 trials (257 patients),8 
was inconclusive due to the limited number of trials. The 
second, including 24 trials (1271 patients), addressed the 
role of epinephrine added to intrathecal LAs.9 Similar to our 
findings, the authors concluded that intrathecal epinephrine 
prolonged the duration of analgesia and motor block as well 
as the time to 2 segments regression and to reach the highest 
sensory block. In contrast to our findings, they also found 
that intrathecal epinephrine increased the incidence of arte-
rial hypotension and PONV, especially with doses ≤100 µg.
What Does This New Analysis Add?
Our systematic review included more trials than previously 
published ones.8,9 We were able to investigate the impact of 
epinephrine added to LAs in various settings, such as labor, 
surgery, or postoperative analgesia. We included TSA to esti-
mate the number of patients needed to reach definite conclu-
sions on benefit and harm, and we adapted α levels to adjust 
for multiple outcomes testing. Interestingly, for most out-
comes, the available IS was still too small to allow for reliable 
conclusions to be drawn. Finally, our analyses are the first to 
evaluate the adjunction of epinephrine to locoregional anes-
thesia.86 When added to an LA used for a sciatic, femoral, 
popliteal, or axillary block, epinephrine is likely to increase 
the duration of postoperative analgesia by about 1 hour.
Weaknesses of Our Analysis
This systematic review has several limitations; most are due 
to weaknesses of the original studies. First, the majority of the 
trials included <50 patients, bearing the risk to report exag-
gerated beneficial effects.87 Second, many outcomes were 
not standardized. This may be due to the lack of a common, 
clearly defined research agenda. Third, we combined out-
comes that were not necessarily the primary outcomes in the 
included trials. Although this may have added heterogeneity 
to our analyses, it also increased their power and generaliz-
ability. Fourth, a large variety of LA regimens were used with 
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different vasoconstrictive properties which may influence their 
pharmacokinetics.88 Fifth, although epinephrine doses varied 
across trials, we were unable to establish dose-responsiveness. 
Finally, although we have adapted the α levels of statistical sig-
nificance to adjust for multiple testing, there is yet no consen-
sus on which method of adjustment should be used, and some 
may not agree with our pragmatic method. Similarly, for the 
purpose of clarity, we have maintained the adjusted α levels 
to perform TSA. The number of missing patients to achieve 
definite conclusions may therefore be overestimated.
Clinical Implications
Epinephrine has been used for many years as an adjuvant 
to LAs with the aim to prolong sensory nerve blockade and 
delay systemic uptake of the LA, thereby reducing the risk of 
anesthetic toxicity. This systematic review suggests that the 
duration of analgesia is likely to be prolonged by about 30 
minutes when epinephrine is added to intrathecal LAs and 
by about 60 minutes when added to locoregional LAs. This 
degree of efficacy must be put into its clinical context. Adding 
clonidine to intermediate or long-acting LAs for a single-shot 
peripheral nerve or plexus block prolongs duration of anal-
gesia by about 120 minutes,89 and to intrathecal LAs, by about 
100 minutes.90 Opioids added to LAs prolong the duration of 
postoperative analgesia even more, that is, by 120 minutes 
with the short-acting fentanyl, and by more than 8 hours with 
morphine.91 Also, adding dexamethasone or dexmedetomi-
dine to LAs was shown to prolong duration of analgesia by 
about 4 and 7 hours, respectively.85,92 These data suggest that 
there are more powerful alternatives than epinephrine to 
prolong analgesia. The question remains, whether epineph-
rine as an adjuvant reduces the risk of systemic LA toxicity. 
However, unless the LA is injected in very high doses, for 
instance, through multiple subcutaneous infiltrations, the 
risk of systemic LA toxicity may be negligible.
Research Agenda
TSA suggested that further trials on epinephrine added to 
intrathecal LAs are probably not needed because its impact 
seems well characterized. However, in the context of labor 
analgesia, when epinephrine is added to an intrathecal or 
epidural LA, the available evidence is still not sufficient to 
conclude on its impact on motor block, on arterial hypoten-
sion, or on the need for instrumentation or cesarean delivery. 
Also, well-designed RCTs are necessary to better character-
ize the impact of epinephrine added to an LA in an epidural 
catheter for both labor and postoperative analgesia. Finally, 
dose-responsiveness and the adequate dose of epinephrine 
that needs to be administrated still need to be defined.
CONCLUSIONS
Adding epinephrine to intrathecal or locoregional LAs 
prolongs analgesia and motor block by 30–60 minutes. The 
impact of adding epinephrine to epidural LAs or to a CSE 
remains uncertain. E
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